• American Biotech Labs (ABL; Salt Lake City) said that the company received FDA approval to market its ASAP Wound Dressing Gel "for the topical management of minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin irritations." The product uses ABL's innovative SilverSol Technology, which has garnered multiple patents in the U.S. and several countries throughout the world, including a broad-use patent that provides the company with exclusive rights to use its silver-based products to combat many of the world's most destructive pathogens, including malaria, tuberculosis, MRSA and HIV. ABL has performed extensive anti-microbial studies against bacteria, yeast, fungus and other pathogens.

• ExpressMD Solutions (Berkeley Heights, New Jersey) said that its remote patient health monitoring system has received 510(k) market clearance from the FDA. ExpressMD plans to initiate manufacturing and sales of its Electronic House Call monitoring devices and services immediately. The Electronic House Call System will be used by healthcare professionals who manage patients with chronic conditions, such as heart disease, COPD (Chronic Obstructive Pulmonary Disease) and diabetes. Patients are able to use the monitoring devices located in their home to measure their vital signs and to motivate them through education and reminders. The Electronic House Call monitor securely transmits this information to its data center making it conveniently available to each licensed care provider via a secure website. By remotely receiving patient data daily, licensed care providers can adjust treatment accordingly and provide an enhanced level of care.

• ProUroCare Medical (Eden Prarie, Minnesota) said it will showcase its ProUroScan system at the American Urological Association (AUA) Annual Scientific Meeting later this month. The ProUroScan system is a patented-imaging system designed to provide a map of the prostate and to store a digital image for review. The company claims that as an adjunctive tool to a digital rectal exam (DRE), this system aids the physician in visualizing and documenting abnormalities in the prostate previously detected by a DRE. The data acquired allows the calculation of prostate features such as size and shape. In addition to the real-time visual image, the results are stored electronically, allowing for comparison of the abnormality's changes over time.

• QImaging (Surrey, British Columbia) reported the introduction of a comprehensive Performance Assurance Plan to assist researchers in meeting research grant productivity goals. The program includes training, equipment maintenance, rapid response, and loaner equipment. The package can be added at time of equipment purchase, and provides scientists with complete peace of mind, so that important research is conducted without interruption.

No Comments